New Delhi: Sanofi Pasteur on Thursday launched Hexaxim, a six-in-one vaccine indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age.
The ready-to-use fully liquid vaccine provides protection against six major childhood diseases — diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenza B and hepatitis B, according to the company.
“Given the large influx of patients met by paediatricians in India, Hexaxim will offer convenience and ensure consistency in administering the right dose of each antigen every single time,” said Jean-Pierre Baylet, country head, Sanofi Pasteur India, Sri Lanka and Nepal.
The burden of the six diseases is significant, particularly in infants. Consequently, the World Health Organization (WHO) and a wide majority of countries around the world recommend vaccination against these diseases.
India, under the Universal Immunization Programme, also offers protection against these six major diseases.
Globally, Hexaxim is the only combination vaccine with acellular pertussis (acP) and inactivated polio vaccines (IPV) to have received a prequalification by the WHO, according to a statement by the company.
The vaccine currently protects infants in more than 60 countries, with over 20 million doses distributed worldwide, the statement said.
The launch of Hexaxim in India marked the end of a long regulatory process that began in 2012. The Regulatory team started local clinical trials in 2014. The results were evaluated by the regulatory authority and expert body, and were followed by site registration and the import license.